X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $61,480.71 -0.25%
Ethereum $1,620.62 -1.05%
BNB $585.87 -1.08%
Optimism $0.09 -5.95%
Arbitrum $0.08 -3.74%
Solana $63.14 -2.68%
Polygon $0.22 +2.77%
Cosmos $1.76 -0.77%
Avalanche $6.39 -3.66%

Bitcoin $61,480.71 -0.25%
Ethereum $1,620.62 -1.05%
BNB $585.87 -1.08%
Optimism $0.09 -5.95%
Arbitrum $0.08 -3.74%
Solana $63.14 -2.68%
Polygon $0.22 +2.77%
Cosmos $1.76 -0.77%
Avalanche $6.39 -3.66%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed